Tab. V.
Variable | n | Delirium, n (%) | No delirium, n (%) | Sig. P-value | Exp (B) OR | 95% CI for Exp(B) OR | ||
---|---|---|---|---|---|---|---|---|
Control group | Melatonin group | Lower | Upper | |||||
Incidence | 20.8% | 8.4% | 0.001 | |||||
Age (years) | 0.001 | 1.098 | 1.063 | 1.134 | ||||
Gender | 0.432 | 1.252 | 0.714 | 2.197 | ||||
EuroSCORE II | 0.001 | 1.314 | 1.203 | 1.435 | ||||
D. mellitus | 0.516 | 1.188 | 0.706 | 2.000 | ||||
Hypertension | 0.218 | 1.942 | 0.675 | 5.583 | ||||
Hypercholest. | 0.709 | 0.898 | 0.508 | 1.584 | ||||
Smoking | 0.353 | 0.779 | 0.461 | 1.319 | ||||
Alcoholism | 0.829 | 1.101 | 0.460 | 2.637 | ||||
Psych. disease | 0.416 | 0.638 | 0.215 | 1.888 | ||||
Operation type | ||||||||
CABG | 0.003 | 2.385 | 1.355 | 4.198 | ||||
OPCAB | 0.547 | 0.771 | 0.331 | 1.798 | ||||
AVR | 0.409 | 1.248 | 0.737 | 2.112 | ||||
MVR | 0.132 | 1.695 | 0.852 | 3.372 | ||||
AVR + MVR | 0.248 | 1.342 | 0.815 | 2.208 | ||||
CABG + AVR | 0.018 | 2.698 | 1.186 | 6.138 | ||||
CABG + MVR | 0.010 | 2.224 | 1.210 | 4.090 | ||||
CABG + AVR + MVR | 0.010 | 2.224 | 1.210 | 4.090 | ||||
CPB time | 0.001 | 1.010 | 1.004 | 1.015 | ||||
ACC time | 0.008 | 1.009 | 1.002 | 1.016 | ||||
Sufentanil d. (mg) > 0.15 | 0.001 | 5.679 | 2.591 | 12.446 | ||||
Benzodiaz. | 0.142 | 0.936 | 0.856 | 1.023 | ||||
M. vent. | 0.033 | 1.078 | 1.006 | 1.155 | ||||
ICU stay | 0.001 | 1.234 | 1.145 | 1.330 | ||||
Hosp. stay | 0.001 | 1.107 | 1.060 | 1.155 |
sig. – significant, Exp(B) – coefficient, OR – odds ratio, CI – confidence interval, D. – diabetes, Hypercholest. – hypercholesterolemia, Psych. – psychiatric, CABG – coronary artery bypass graft surgery, OPCAB – off-pump coronary artery bypass, AVR – aortic valve replacement, MVR – mitral valve replacement, CPB – cardio-pulmonary bypass, ACC – aortic cross-clamping, d. – dose, Benzodiaz. – benzodiazepine, M. vent. – mechanical ventilation, ICU – intensive care unit, Hosp. – hospitalization